Clinical Applications of Molecular Biomarkers in Prostate Cancer

被引:27
作者
Counago, Felipe [1 ,2 ,3 ]
Lopez-Campos, Fernando [4 ]
Diaz-Gavela, Ana Aurora [1 ,2 ,3 ]
Almagro, Elena [5 ]
Fenandez-Pascual, Esau [6 ,7 ]
Henriquez, Ivan [8 ]
Lozano, Rebeca [9 ,10 ]
Espinos, Estefania Linares [6 ,7 ]
Gomez-Iturriaga, Alfonso [11 ]
de Velasco, Guillermo [12 ]
Franco, Luis Miguel Quintana [7 ]
Rodriguez-Melcon, Ignacio [13 ]
Lopez-Torrecilla, Jose [14 ]
Spratt, Daniel E. [15 ]
Guerrero, Luis Leonardo [1 ,2 ,3 ]
Martinez-Salamanca, Juan Ignacio [6 ,16 ]
del Cerro, Elia [1 ,2 ,3 ]
机构
[1] Hosp Univ Quironsalud Madrid, Radiat Oncol, Madrid 28223, Spain
[2] Hosp La Luz, Radiat Oncol, Madrid 28003, Spain
[3] Univ Europea Madrid, Clin Dept, Fac Biomed, Madrid 28670, Spain
[4] Hosp Univ Ramon y Cajal, Radiat Oncol, Madrid 28034, Spain
[5] Hosp Univ Quironsalud Madrid, Med Oncol, Madrid 28223, Spain
[6] Univ Francisco Vitoria, Lyx Inst Urol, Madrid 28006, Spain
[7] Univ La Paz, Dept Urol, Madrid 28046, Spain
[8] Hosp Univ St Joan, Radiat Oncol, Reus 43204, Spain
[9] Spanish Natl Canc Res Ctr, Prostate Canc Clin Res Unit, Madrid 28029, Spain
[10] Inst Biomed Res, Genitourinary Canc Traslat Res Grp, Malaga 29010, Spain
[11] Biocruces Heath Res Inst, Cruces Univ Hosp, Baracaldo 48903, Spain
[12] Hosp Univ 12 Octubre, Med Oncol, Madrid 28041, Spain
[13] Hosp Univ Gran Canaria Dr Negrin, Radiat Oncol, Las Palmas Gran Canaria 35010, Spain
[14] Hosp Gen Univ Valencia, Radiat Oncol ERESA, Valencia 46014, Spain
[15] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA
[16] Hosp Univ Puerta Hierro, Dept Urol, Madrid 28222, Spain
关键词
biomarkers; DNA repair; gene panels; genetic testing; germline mutation; precision medicine; prostate cancer; prostate genomics; CYCLE PROGRESSION SCORE; CIRCULATING TUMOR-CELLS; BIOCHEMICAL FAILURE; RISK STRATIFICATION; RADICAL PROSTATECTOMY; GENOMIC CLASSIFIER; RADIATION-THERAPY; BRCA MUTATIONS; GENE FUSIONS; PATIENTS PTS;
D O I
10.3390/cancers12061550
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
There is clinically relevant molecular heterogeneity in prostate cancer (PCa), but this biological diversity has had only a minimal impact on clinical practice. Treatment outcomes in patients with localised PCa are often highly variable, even among patients stratified to the same risk group or disease state based on standard clinical and pathological parameters. In recent years, the development of gene panels has provided valuable data on the differential expression of genes in patients with PCa. Nevertheless, there is an urgent need to identify and validate prognostic and predictive biomarkers that can be applied across clinical scenarios, ranging from localised disease to metastatic castration-resistant PCa. The availability of such tools would allow for precision medicine to finally reach PCa patients. In this review, we evaluate current data on molecular biomarkers for PCa, with an emphasis on the biomarkers and gene panels with the most robust evidence to support their application in routine clinical practice.
引用
收藏
页码:1 / 25
页数:24
相关论文
共 133 条
[1]  
Abida W, 2019, ANN ONCOL, V30, P327
[2]   Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study [J].
Abida, Wassim ;
Campbell, David ;
Patnaik, Akash ;
Shapiro, Jeremy D. ;
Sautois, Brieuc ;
Vogelzang, Nicholas J. ;
Voog, Eric G. ;
Bryce, Alan H. ;
McDermott, Ray ;
Ricci, Francesco ;
Rowe, Julie ;
Zhang, Jingsong ;
Piulats, Josep Maria ;
Fizazi, Karim ;
Merseburger, Axel S. ;
Higano, Celestia S. ;
Krieger, Laurence E. ;
Ryan, Charles J. ;
Feng, Felix Y. ;
Simmons, Andrew D. ;
Loehr, Andrea ;
Despain, Darrin ;
Dowson, Melanie ;
Green, Foad ;
Watkins, Simon P. ;
Golsorkhi, Tony ;
Chowdhury, Simon .
CLINICAL CANCER RESEARCH, 2020, 26 (11) :2487-2496
[3]   Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making [J].
Abida, Wassim ;
Armenia, Joshua ;
Gopalan, Anuradha ;
Brennan, Ryan ;
Walsh, Michael ;
Barron, David ;
Danila, Daniel ;
Rathkopf, Dana ;
Morris, Michael ;
Slovin, Susan ;
McLaughlin, Brigit ;
Curtis, Kristen ;
Hyman, David M. ;
Durack, Jeremy C. ;
Solomon, Stephen B. ;
Arcila, Maria E. ;
Zehir, Ahmet ;
Syed, Aijazuddin ;
Gao, Jianjiong ;
Chakravarty, Debyani ;
Vargas, Hebert Alberto ;
Robson, Mark E. ;
Vijai, Joseph ;
Offit, Kenneth ;
Donoghue, Mark T. A. ;
Abeshouse, Adam A. ;
Kundra, Ritika ;
Heins, Zachary J. ;
Penson, Alexander V. ;
Harris, Christopher ;
Taylor, Barry S. ;
Ladanyi, Marc ;
Mandelker, Diana ;
Zhang, Liying ;
Reuter, Victor E. ;
Kantoff, Philip W. ;
Solit, David B. ;
Berger, Michael F. ;
Sawyers, Charles L. ;
Schultz, Nikolaus ;
Scher, Howard I. .
JCO PRECISION ONCOLOGY, 2017, 1 :1-26
[4]   Genomic correlates of clinical outcome in advanced prostate cancer [J].
Abida, Wassim ;
Cyrta, Joanna ;
Heller, Glenn ;
Prandi, Davide ;
Armenia, Joshua ;
Coleman, Ilsa ;
Cieslik, Marcin ;
Benelli, Matteo ;
Robinson, Dan ;
Van Allen, Eliezer M. ;
Sboner, Andrea ;
Fedrizzi, Tarcisio ;
Mosquera, Juan Miguel ;
Robinson, Brian D. ;
De Sarkar, Navonil ;
Kunju, Lakshmi P. ;
Tomlins, Scott ;
Wu, Yi Mi ;
Rodrigues, Daniel Nava ;
Loda, Massimo ;
Gopalan, Anuradha ;
Reuter, Victor E. ;
Pritchard, Colin C. ;
Mateo, Joaquin ;
Bianchini, Diletta ;
Miranda, Susana ;
Carreira, Suzanne ;
Rescigno, Pasquale ;
Filipenko, Julie ;
Vinson, Jacob ;
Montgomery, Robert B. ;
Beltran, Himisha ;
Heath, Elisabeth I. ;
Scher, Howard I. ;
Kantoff, Philip W. ;
Taplin, Mary-Ellen ;
Schultz, Nikolaus ;
deBono, Johann S. ;
Demichelis, Francesca ;
Nelson, Peter S. ;
Rubin, Mark A. ;
Chinnaiyan, Arul M. ;
Sawyers, Charles L. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (23) :11428-11436
[5]   Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade [J].
Abida, Wassim ;
Cheng, Michael L. ;
Armenia, Joshua ;
Middha, Sumit ;
Autio, Karen A. ;
Vargas, Hebert Alberto ;
Rathkopf, Dana ;
Morris, Michael J. ;
Danila, Daniel C. ;
Slovin, Susan F. ;
Carbone, Emily ;
Barnett, Ethan S. ;
Hullings, Melanie ;
Hechtman, Jaclyn F. ;
Zehir, Ahmet ;
Shia, Jinru ;
Jonsson, Philip ;
Stadler, Zsofia K. ;
Srinivasan, Preethi ;
Laudone, Vincent P. ;
Reuter, Victor ;
Wolchok, Jedd D. ;
Socci, Nicholas D. ;
Taylor, Barry S. ;
Berger, Michael F. ;
Kantoff, Philip W. ;
Sawyers, Charles L. ;
Schultz, Nikolaus ;
Solit, David B. ;
Gopalan, Anuradha ;
Scher, Howard I. .
JAMA ONCOLOGY, 2019, 5 (04) :471-478
[6]  
Advice N., 2018, BJU INT, V122, P173, DOI [10.1111/bju.14452, DOI 10.1111/BJU.14452]
[7]   A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer [J].
Ahearn, Thomas U. ;
Pettersson, Andreas ;
Ebot, Ericka M. ;
Gerke, Travis ;
Graff, Rebecca E. ;
Morais, Carlos L. ;
Hicks, Jessica L. ;
Wilson, Kathryn M. ;
Rider, Jennifer R. ;
Sesso, Howard D. ;
Fiorentino, Michelangelo ;
Flavin, Richard ;
Finn, Stephen ;
Giovannucci, Edward L. ;
Loda, Massimo ;
Stampfer, Meir J. ;
De Marzo, Angelo M. ;
Mucci, Lorelei A. ;
Lotan, Tamara L. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (02)
[8]  
Amin M B., 2018, AJCC Cancer Staging Form Supplement, V8th
[9]   Genome-Based Classification and Therapy of Prostate Cancer [J].
Angeles, Arlou Kristina ;
Bauer, Simone ;
Ratz, Leonie ;
Klauck, Sabine M. ;
Sueltmann, Holger .
DIAGNOSTICS, 2018, 8 (03)
[10]   Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer [J].
Annala, Matti ;
Vandekerkhove, Gillian ;
Khalaf, Daniel ;
Taavitsainen, Sinja ;
Beja, Kevin ;
Warner, Evan W. ;
Sunderland, Katherine ;
Kollmannsberger, Christian ;
Eigl, Bernhard J. ;
Finch, Daygen ;
Oja, Conrad D. ;
Vergidis, Joanna ;
Zulfiqar, Muhammad ;
Azad, Arun A. ;
Nykter, Matti ;
Gleave, Martin E. ;
Wyatt, Alexander W. ;
Chi, Kim N. .
CANCER DISCOVERY, 2018, 8 (04) :444-457